TYK2 as a novel therapeutic target in Alzheimer Disease
Laura E. König, Steve Rodriguez, Clemens B. Hug…·Mark W. Albers
The paper identifies TYK2 as a potential therapeutic target for neurodegenerative diseases by linking cdsRNA-induced inflammation to interferon signaling and demonstrating protective effects of TYK2 inhibitors.